ZOLL Medical, a part of the Asahi Kasei Group, won EU clearance for its SuperSaturated Oxygen (SSO2) Therapy System to be used to minimize the damage that heart attacks cause within heart muscle.
Approved about a year ago in the United States, SSO2 is the only option beyond percutaneous coronary intervention (stenting) that can help stric (Read more...)